What Is An Adaptogen?

Adaptogens help the body and brain cells "adapt" to and resist physical, chemical and environmental stress. They also help the body by normalizing the immune system and certain hormone levels in a positive way to bring them into balance.

Rhodiola rosea is an adaptogen with a common name called “Golden Root”. It has more than 45 years of clinical studies and has been used in natural medicine for over a thousand years.

How could something so good and with such a history evade the medical community of the US?

Five reasons:

  1. There are 20 species of Adaptogens; most are unknown in the US market because they exist outside of the US.
  2. Rhodiola rosea was kept as a “Soviet Secret” until after the Soviet Union collapsed. For those living in the Altai mountain range of Siberia, Rhodiola rosea has always been known as a natural medicine to help the body and brain cells "adapt".
  3. Since it is natural, US drug companies are not interested in something they cannot patent
  4. Alternative companies here in the US are not compelled by the FDA to run clinical trials nor do most have the money to invest in them.
  5. It was not standardized until recent years. However, with that said here are reasons why you might want to investigate this compound.

Rhodiola rosea has 45 years of documented clinical studies in Europe and has been used in practice by professionals here in the United States for more that 12 years under the brand name ROSAVIN or ROSAVIN Plus.

Rhodiola rosea (ROSAVIN) only has a couple minor side effects - heightened dreams and agitations at high amounts. Many professionals are claiming side benefits rather than side effects and ROSAVIN can be taken with most drugs.

It’s safe and inexpensive.

The only draw back might be that health plans do not cover it, but then most health plans today have co-pays exceeding the cost of purchasing ROSAVIN online.

You need a brand you can trust. Ameriden brought it to the professional market in 1995 and it’s the only standardized brand used in U.S. case studies.